This study demonstrated the inhibitory effect of dauriporphine on the viability, motility, and energy metabolism of lung cancer cells, and the miR-424-5p/MAPK14 axis was revealed as the downstream molecular mechanism. This evidence concerns the gene MAPK14 and lung carcinoma.